Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 225

1.

Serotonin transporter-blocking properties of nefazodone assessed by measurement of platelet serotonin.

Narayan M, Anderson G, Cellar J, Mallison RT, Price LH, Nelson JC.

J Clin Psychopharmacol. 1998 Feb;18(1):67-71.

PMID:
9472845
[PubMed - indexed for MEDLINE]
2.

The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies.

Owens MJ, Ieni JR, Knight DL, Winders K, Nemeroff CB.

Life Sci. 1995;57(24):PL373-80.

PMID:
7475971
[PubMed - indexed for MEDLINE]
3.

Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine.

Gilmor ML, Owens MJ, Nemeroff CB.

Am J Psychiatry. 2002 Oct;159(10):1702-10.

PMID:
12359676
[PubMed - indexed for MEDLINE]
4.
5.

Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs.

Epperson N, Czarkowski KA, Ward-O'Brien D, Weiss E, Gueorguieva R, Jatlow P, Anderson GM.

Am J Psychiatry. 2001 Oct;158(10):1631-7.

PMID:
11578995
[PubMed - indexed for MEDLINE]
6.

Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.

Bakish D, Cavazzoni P, Chudzik J, Ravindran A, Hrdina PD.

Biol Psychiatry. 1997 Jan 15;41(2):184-90.

PMID:
9018388
[PubMed - indexed for MEDLINE]
7.

Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.

Sussman N, Ginsberg DL, Bikoff J.

J Clin Psychiatry. 2001 Apr;62(4):256-60.

PMID:
11379839
[PubMed - indexed for MEDLINE]
8.

Platelet serotonin reuptake inhibition and response to SSRIs in depressed adolescents.

Axelson DA, Perel JM, Birmaher B, Rudolph G, Nuss S, Yurasits L, Bridge J, Brent DA.

Am J Psychiatry. 2005 Apr;162(4):802-4.

PMID:
15800159
[PubMed - indexed for MEDLINE]
9.

LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodone.

Pullar IA, Carney SL, Colvin EM, Lucaites VL, Nelson DL, Wedley S.

Eur J Pharmacol. 2000 Oct 27;407(1-2):39-46.

PMID:
11050288
[PubMed - indexed for MEDLINE]
10.

Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia.

Anderson GM, Gutknecht L, Cohen DJ, Brailly-Tabard S, Cohen JH, Ferrari P, Roubertoux PL, Tordjman S.

Mol Psychiatry. 2002;7(8):831-6.

PMID:
12232775
[PubMed - indexed for MEDLINE]
Free Article
11.

Fluvoxamine treatment of mixed anxiety and depression: evidence for serotonergically mediated anxiolysis.

Rausch JL, Hobby HM, Shendarkar N, Johnson ME, Li J.

J Clin Psychopharmacol. 2001 Apr;21(2):139-42.

PMID:
11270909
[PubMed - indexed for MEDLINE]
12.

Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.

Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP.

J Clin Psychiatry. 1999 Apr;60(4):226-31.

PMID:
10221282
[PubMed - indexed for MEDLINE]
13.

Differential physiological effects of a low dose and high doses of venlafaxine in major depression.

Debonnel G, Saint-André E, Hébert C, de Montigny C, Lavoie N, Blier P.

Int J Neuropsychopharmacol. 2007 Feb;10(1):51-61. Epub 2006 May 11.

PMID:
16690006
[PubMed - indexed for MEDLINE]
14.

Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter.

Benmansour S, Owens WA, Cecchi M, Morilak DA, Frazer A.

J Neurosci. 2002 Aug 1;22(15):6766-72.

PMID:
12151556
[PubMed - indexed for MEDLINE]
Free Article
15.

Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.

Epperson CN, Jatlow PI, Czarkowski K, Anderson GM.

Pediatrics. 2003 Nov;112(5):e425.

PMID:
14595087
[PubMed - indexed for MEDLINE]
16.

Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder.

Delorme R, Chabane N, Callebert J, Falissard B, Mouren-Siméoni MC, Rouillon F, Launay JM, Leboyer M.

J Clin Psychopharmacol. 2004 Feb;24(1):18-23.

PMID:
14709942
[PubMed - indexed for MEDLINE]
17.

Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction.

Sauer WH, Berlin JA, Kimmel SE.

Circulation. 2003 Jul 8;108(1):32-6. Epub 2003 Jun 23.

PMID:
12821544
[PubMed - indexed for MEDLINE]
Free Article
18.

Nefazodone treatment of adolescent depression: an open-label study of response and biochemistry.

Goodnick PJ, Jorge CA, Hunter T, Kumar AM.

Ann Clin Psychiatry. 2000 Jun;12(2):97-100.

PMID:
10907801
[PubMed - indexed for MEDLINE]
19.

The influence of selective serotonin reuptake inhibitors on human platelet serotonin.

Maurer-Spurej E, Pittendreigh C, Solomons K.

Thromb Haemost. 2004 Jan;91(1):119-28.

PMID:
14691577
[PubMed - indexed for MEDLINE]
20.

Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.

Augustin BG, Cold JA, Jann MW.

Pharmacotherapy. 1997 May-Jun;17(3):511-30. Review.

PMID:
9165554
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk